Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melissa Officinalis for Sleep Bruxism in Children
NCT06214637Phase 1Recruiting
- Sponsor
- Federal University of Rio de Janeiro
- Start
- Aug 2023
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, triple-blind trial of melissa officinalis in sleep bruxism (4 arms), sponsored by Federal University of Rio de Janeiro. Primary endpoint: General objective. Started Aug 2023; status: recruiting.
02
Drugs
melissa officinalis
03
Conditions
sleep bruxism
Beyond the preview
Go deeper on NCT06214637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06214637.